Barclays
HAIAW

Barclays’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Barclays’s Portfolio HAIAW Stock Details HAIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-62,809
Closed -$718K – 5679
2024
Q4 		$718K Hold
62,809
– – ﹤0.01% 3598
2024
Q3 		$1.88K Hold
62,809
– – ﹤0.01% 5090
2024
Q2 		$710K Hold
62,809
– – ﹤0.01% 2804
2024
Q1 		$2.75K Hold
62,809
– – ﹤0.01% 4896
2023
Q4 		$1.58K Hold
62,809
– – ﹤0.01% 5088
2023
Q3 		$2.76K Hold
62,809
– – ﹤0.01% 4437
2023
Q2 		$5.5K Hold
62,809
– – ﹤0.01% 4269
2023
Q1 		$655K Hold
62,809
– – ﹤0.01% 3067
2022
Q4 		$644K Hold
62,809
– – ﹤0.01% 3138
2022
Q3 		$8K Hold
62,809
– – ﹤0.01% 4401
2022
Q2 		$8K Hold
62,809
– – ﹤0.01% 4703
2022
Q1 		$10K Buy
+62,809
New +$18.9K ﹤0.01% 4608

Barclays's HAIAW Position: Q1 2025 in Review

Barclays sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q1 2025, closing a stake of 62,809 shares — an estimated $718K sold.

Barclays first reported a position in HAIAW in Q1 2022 and held it in 12 quarters. The position peaked at $718K in Q4 2024. 0 funds tracked by Wall St. Rank hold HAIAW as of Q1 2025.

  • Barclays reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 62,809 Healthcare AI Acquisition Corp. Warrants shares in Q1 2025, an estimated $718K.
  • Barclays first reported a position in Healthcare AI Acquisition Corp. Warrants in Q1 2022 and held it in 12 quarters.
  • Barclays's Healthcare AI Acquisition Corp. Warrants position peaked at $718K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.